tradingkey.logo

Myomo Inc

MYO
0.863USD
+0.022+2.67%
Close 11/05, 16:00ETQuotes delayed by 15 min
32.60MMarket Cap
LossP/E TTM

Myomo Inc

0.863
+0.022+2.67%

More Details of Myomo Inc Company

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.

Myomo Inc Info

Ticker SymbolMYO
Company nameMyomo Inc
IPO dateJun 12, 2017
CEOMr. Paul R. Gudonis
Number of employees184
Security typeOrdinary Share
Fiscal year-endJun 12
Address137 Portland Street
CityBOSTON
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code02114
Phone16179969058
Websitehttps://myomo.com/
Ticker SymbolMYO
IPO dateJun 12, 2017
CEOMr. Paul R. Gudonis

Company Executives of Myomo Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.25M
-0.79%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
474.42K
+26.71%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
427.90K
+11.59%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+45.75%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+246.97%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.25M
-0.79%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
474.42K
+26.71%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
427.90K
+11.59%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+45.75%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+246.97%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
By BusinessUSD
Name
Revenue
Proportion
Direct to patient
7.42M
76.88%
Clinical/Medical providers
2.23M
23.12%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Direct to patient
7.42M
76.88%
Clinical/Medical providers
2.23M
23.12%

Shareholding Stats

Updated: Sat, Nov 1
Updated: Sat, Nov 1
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Rosalind Advisors, Inc.
9.51%
Herr Investment Group LLC
7.53%
Triple Gate Capital, LP
7.47%
BlackRock Institutional Trust Company, N.A.
4.00%
The Vanguard Group, Inc.
3.94%
Other
67.55%
Shareholders
Shareholders
Proportion
Rosalind Advisors, Inc.
9.51%
Herr Investment Group LLC
7.53%
Triple Gate Capital, LP
7.47%
BlackRock Institutional Trust Company, N.A.
4.00%
The Vanguard Group, Inc.
3.94%
Other
67.55%
Shareholder Types
Shareholders
Proportion
Hedge Fund
22.96%
Investment Advisor
22.00%
Investment Advisor/Hedge Fund
10.68%
Individual Investor
7.42%
Research Firm
2.77%
Venture Capital
0.16%
Pension Fund
0.16%
Bank and Trust
0.09%
Other
33.75%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
153
22.25M
58.86%
-1.76M
2025Q2
131
25.59M
71.13%
+1.42M
2025Q1
128
23.88M
66.62%
+977.96K
2024Q4
112
23.29M
69.71%
+5.81M
2024Q3
85
19.54M
71.85%
+1.13M
2024Q2
79
18.43M
69.76%
+448.58K
2024Q1
77
16.43M
64.97%
-1.27M
2023Q4
72
14.80M
62.04%
-346.58K
2023Q3
64
15.22M
79.76%
+6.49M
2023Q2
62
8.10M
62.40%
+2.44M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Rosalind Advisors, Inc.
3.60M
9.51%
+892.13K
+33.00%
Jun 30, 2025
Herr Investment Group LLC
2.85M
7.53%
+1.20M
+72.93%
Jun 30, 2024
Triple Gate Capital, LP
2.83M
7.47%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.51M
4%
+1.40M
+1213.08%
Jun 30, 2025
The Vanguard Group, Inc.
1.49M
3.94%
+226.35K
+17.94%
Jun 30, 2025
Gudonis (Paul R)
1.25M
3.3%
-10.00K
-0.79%
Sep 09, 2025
Journey Advisory Group, LLC
875.84K
2.32%
-248.95K
-22.13%
Jun 30, 2025
Worth Venture Partners, LLC
875.76K
2.32%
-312.69K
-26.31%
Jun 30, 2025
Soleus Capital Management, L.P.
704.27K
1.86%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
669.28K
1.77%
+412.63K
+160.78%
Jun 30, 2025
View more

Related ETFs

Updated: Sun, Nov 2
Updated: Sun, Nov 2
Name
Proportion
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Micro-Cap ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
ProShares UltraPro Russell2000
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI